Susan H Fox Selected Research

Susan H Fox Research Topics

Disease

87	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2002
71	Dyskinesias (Dyskinesia) 07/2022 - 11/2002
15	Parkinsonian Disorders (Parkinsonism) 01/2022 - 07/2005
15	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 09/2006
6	Dystonia (Limb Dystonia) 07/2021 - 01/2002
6	Tremor (Tremors) 10/2020 - 09/2013
4	Disease Progression 07/2022 - 01/2010
4	Hallucinations (Hallucination) 09/2017 - 11/2004
4	Chorea (Rheumatic Chorea) 09/2014 - 06/2006
3	Sialorrhea 12/2020 - 11/2007
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2020 - 02/2011
3	Mood Disorders (Mood Disorder) 01/2018 - 12/2012
2	Cognitive Dysfunction 01/2019 - 05/2012
2	Pain (Aches) 01/2018 - 09/2016
2	Hypokinesia (Bradykinesia) 03/2015 - 05/2014
2	Gambling (Pathological Gambling) 10/2011 - 02/2007
1	Epilepsy (Aura) 07/2021
1	Torticollis (Wryneck) 07/2021
1	Huntington Disease (Huntington's Disease) 01/2019
1	Intractable Pain 09/2016
1	Dyspepsia (Indigestion) 03/2015
1	Diabetes Mellitus 03/2015

Drug/Important Bio-Agent (IBA)

70	Levodopa (L Dopa)FDA LinkGeneric 07/2022 - 11/2002
28	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022 - 11/2002
17	Dopamine (Intropin)FDA LinkGeneric 10/2020 - 07/2005
11	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 01/2008
9	Amantadine (Aman)FDA LinkGeneric 10/2020 - 11/2006
9	Clozapine (Clozaril)FDA LinkGeneric 01/2020 - 11/2006
9	Pharmaceutical PreparationsIBA 01/2016 - 11/2005
5	Quetiapine Fumarate (Seroquel)FDA Link 01/2020 - 11/2006
5	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 11/2006
4	Dopamine Agonists (Dopamine Agonist)IBA 01/2020 - 11/2004
4	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 11/2007
4	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 09/2017 - 04/2010
3	Apomorphine FDA Link 10/2020 - 11/2004
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2013
3	5-HT1A Serotonin ReceptorIBA 10/2015 - 01/2012
3	Dihydroxyphenylalanine (Dopa)IBA 06/2013 - 02/2009
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 12/2020 - 10/2011
2	Rivastigmine (Exelon)FDA LinkGeneric 10/2020 - 10/2011
2	N-Methylaspartate (NMDA)IBA 11/2018 - 09/2013
2	Type A Botulinum Toxins (Botox)FDA Link 01/2018 - 10/2011
2	oxidized low density lipoproteinIBA 01/2018 - 03/2013
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2016 - 03/2013
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2016 - 01/2015
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016 - 09/2013
2	3- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA 02/2015 - 08/2012
2	Famotidine (Pepcid)FDA LinkGeneric 09/2014 - 07/2010
2	N- methyl- 1- cyclopropyl- 1- piperonylmethylamineIBA 07/2014 - 01/2012
2	Antidepressive Agents (Antidepressants)IBA 09/2013 - 10/2011
2	fipamezoleIBA 09/2013 - 08/2003
2	Dopamine Agents (Dopaminergic Agents)IBA 09/2013 - 05/2012
2	Dopamine AntagonistsIBA 06/2013 - 01/2008
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 05/2012 - 01/2012
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 05/2012 - 05/2011
2	Pramipexole (Mirapex)FDA LinkGeneric 10/2011 - 10/2011
2	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 10/2011 - 11/2007
2	Pergolide (Permax)FDA Link 10/2011 - 10/2011
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2002 - 01/2002
2	Cannabinoid Receptor AgonistsIBA 11/2002 - 01/2002
2	nabilone (Cesamet)FDA Link 11/2002 - 01/2002
1	Investigational DrugsIBA 07/2022
1	Excitatory Amino Acid AntagonistsIBA 07/2021
1	AMPA Receptors (AMPA Receptor)IBA 07/2021
1	perampanelIBA 07/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2021
1	Calcium Channels (Calcium Channel)IBA 10/2020
1	ElementsIBA 01/2019
1	pridopidineIBA 01/2019
1	Capsules (Microcapsules)IBA 11/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	CannabinoidsIBA 01/2018
1	DPI-289IBA 01/2018
1	safinamideIBA 02/2017
1	Sigma-1 ReceptorIBA 01/2017
1	Quinidine (Chinidin)FDA LinkGeneric 01/2017
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2016
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	Urea (Carbamide)FDA LinkGeneric 03/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2015
1	PPAR gammaIBA 03/2015
1	Pioglitazone (Actos)FDA Link 03/2015
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 02/2015
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2015
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2015
1	Histamine H2 AntagonistsIBA 09/2014
1	Histamine H2 ReceptorsIBA 09/2014

Therapy/Procedure

25	Therapeutics 10/2020 - 11/2006
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2017
2	Aftercare (After-Treatment) 01/2018 - 05/2012
2	Injections 01/2018 - 09/2016
2	Deep Brain Stimulation 07/2016 - 04/2011
2	Activities of Daily Living (ADL) 09/2014 - 05/2012